Novartis
NVS
1,146 hedge funds and large institutions have $18.5B invested in Novartis in 2021 Q4 according to their latest regulatory filings, with 156 funds opening new positions, 328 increasing their positions, 473 reducing their positions, and 75 closing their positions.
148% more call options, than puts
Call options by funds: $688M | Put options by funds: $278M
108% more first-time investments, than exits
New positions opened: 156 | Existing positions closed: 75
6% more funds holding
Funds holding: 1,081 → 1,146 (+65)
3% more capital invested
Capital invested by funds: $18B → $18.5B (+$505M)
0.35% less ownership
Funds ownership: 9.03% → 8.68% (-0.35%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 473
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$196M |
| 2 |
D.E. Shaw & Co
New York
|
+$149M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$83.3M |
| 4 |
Two Sigma Advisers
New York
|
+$64.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$58.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aristotle Capital Management
Los Angeles,
California
|
-$628M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$178M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$118M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$86.8M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$84.4M |
NVS Hedge Fund Activity: Q4 2021 in Review
1,146 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q4 2021, worth a combined $18.5B — up 2.8% from $18B a quarter earlier.
Buyers outnumbered sellers: 156 funds opened new NVS positions and 75 closed out — a net gain of 81 holders — while 328 added to existing stakes and 473 trimmed.
The largest buyer was Franklin Resources, adding an estimated $196M. The largest seller was Aristotle Capital Management, cutting an estimated $628M.
- 1,146 institutional investors held Novartis (NVS) as of Q4 2021, up from 1,081 in Q3 2021.
- Funds reported $18.5B of Novartis stock for Q4 2021, up 2.8% quarter-over-quarter.
- 156 funds opened new Novartis positions in Q4 2021 and 75 closed out, a net change of +81 holders.
- The largest Novartis buyer in Q4 2021 was Franklin Resources, an estimated $196M added.
- The largest Novartis seller in Q4 2021 was Aristotle Capital Management, an estimated $628M sold.
Based on aggregated 13F filings for Q4 2021.